BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21530184)

  • 1. Post-exposure therapy of inhalational anthrax in the common marmoset.
    Nelson M; Stagg AJ; Stevens DJ; Brown MA; Pearce PC; Simpson AJ; Lever MS
    Int J Antimicrob Agents; 2011 Jul; 38(1):60-4. PubMed ID: 21530184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental respiratory anthrax infection in the common marmoset (Callithrix jacchus).
    Lever MS; Stagg AJ; Nelson M; Pearce P; Stevens DJ; Scott EA; Simpson AJ; Fulop MJ
    Int J Exp Pathol; 2008 Jun; 89(3):171-9. PubMed ID: 18460069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (postexposure) rhesus monkey model.
    Kao LM; Bush K; Barnewall R; Estep J; Thalacker FW; Olson PH; Drusano GL; Minton N; Chien S; Hemeryck A; Kelley MF
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3535-42. PubMed ID: 17065619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
    Weiss S; Altboum Z; Glinert I; Schlomovitz J; Sittner A; Bar-David E; Kobiler D; Levy H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7497-503. PubMed ID: 26392505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.
    Heine HS; Bassett J; Miller L; Hartings JM; Ivins BE; Pitt ML; Fritz D; Norris SL; Byrne WR
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1373-9. PubMed ID: 17296745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A short course of antibiotic treatment is effective in preventing death from experimental inhalational anthrax after discontinuing antibiotics.
    Vietri NJ; Purcell BK; Tobery SA; Rasmussen SL; Leffel EK; Twenhafel NA; Ivins BE; Kellogg MD; Webster WM; Wright ME; Friedlander AM
    J Infect Dis; 2009 Feb; 199(3):336-41. PubMed ID: 19099484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. US Food and Drug Administration approval of ciprofloxacin hydrochloride for management of postexposure inhalational anthrax.
    Meyerhoff A; Albrecht R; Meyer JM; Dionne P; Higgins K; Murphy D
    Clin Infect Dis; 2004 Aug; 39(3):303-8. PubMed ID: 15306995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.
    Brook I; Germana A; Giraldo DE; Camp-Hyde TD; Bolduc DL; Foriska MA; Elliott TB; Thakar JH; Shoemaker MO; Jackson WE; Ledney GD
    J Antimicrob Chemother; 2005 Dec; 56(6):1074-80. PubMed ID: 16239289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Combination Drug Therapy for Treatment of Antibiotic-Resistant Inhalation Anthrax in a Murine Model.
    Heine HS; Shadomy SV; Boyer AE; Chuvala L; Riggins R; Kesterson A; Myrick J; Craig J; Candela MG; Barr JR; Hendricks K; Bower WA; Walke H; Drusano GL
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696235
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax.
    Heine HS; Bassett J; Miller L; Bassett A; Ivins BE; Lehoux D; Arhin FF; Parr TR; Moeck G
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3350-7. PubMed ID: 18606841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Bacillus anthracis Infection in BALB/c Mice and Cynomolgus Macaques.
    Grossman TH; Anderson MS; Drabek L; Gooldy M; Heine HS; Henning LN; Lin W; Newman JV; Nevarez R; Siefkas-Patterson K; Radcliff AK; Sutcliffe JA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioterrorism. Researchers question obsession with Cipro.
    Enserink M
    Science; 2001 Oct; 294(5543):759-61. PubMed ID: 11679638
    [No Abstract]   [Full Text] [Related]  

  • 13. Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With Ciprofloxacin.
    Vietri NJ; Tobery SA; Chabot DJ; Ingavale S; Somerville BC; Miller JA; Schellhase CW; Twenhafel NA; Fetterer DP; Cote CK; Klimko CP; Boyer AE; Woolfitt AR; Barr JR; Wright ME; Friedlander AM
    J Infect Dis; 2021 Feb; 223(2):319-325. PubMed ID: 32697310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case report of inhalation anthrax acquired naturally.
    Azarkar Z; Bidaki MZ
    BMC Res Notes; 2016 Mar; 9():141. PubMed ID: 26939756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling low-dose mortality and disease incubation period of inhalational anthrax in the rabbit.
    Gutting BW; Marchette D; Sherwood R; Andrews GA; Director-Myska A; Channel SR; Wolfe D; Berger AE; Mackie RS; Watson BJ; Rukhin A
    J Theor Biol; 2013 Jul; 329():20-31. PubMed ID: 23567649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhalational anthrax (Ames aerosol) in naïve and vaccinated New Zealand rabbits: characterizing the spread of bacteria from lung deposition to bacteremia.
    Gutting BW; Nichols TL; Channel SR; Gearhart JM; Andrews GA; Berger AE; Mackie RS; Watson BJ; Taft SC; Overheim KA; Sherwood RL
    Front Cell Infect Microbiol; 2012; 2():87. PubMed ID: 22919678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-exposure prophylaxis of systemic anthrax in mice and treatment with fluoroquinolones.
    Steward J; Lever MS; Simpson AJ; Sefton AM; Brooks TJ
    J Antimicrob Chemother; 2004 Jul; 54(1):95-9. PubMed ID: 15163650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Daptomycin against Bacillus anthracis in a murine model of anthrax spore inhalation.
    Heine HS; Bassett J; Miller L; Purcell BK; Byrne WR
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4471-3. PubMed ID: 20643899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program.
    Martin SW; Tierney BC; Aranas A; Rosenstein NE; Franzke LH; Apicella L; Marano N; McNeil MM
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):393-401. PubMed ID: 15717323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raxibacumab for the treatment of inhalational anthrax.
    Migone TS; Subramanian GM; Zhong J; Healey LM; Corey A; Devalaraja M; Lo L; Ullrich S; Zimmerman J; Chen A; Lewis M; Meister G; Gillum K; Sanford D; Mott J; Bolmer SD
    N Engl J Med; 2009 Jul; 361(2):135-44. PubMed ID: 19587338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.